Cargando…
REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma
Renal cell carcinoma (RCC) is the most common malignant disease of kidney in adults. The proteasome activator REGγ was previously reported to promote the degradation of multiple important regulatory proteins and involved in the progression and development of numerous human cancers. Here, we first re...
Autores principales: | Chen, Shaojun, Wang, Qingwei, Wang, Longsheng, Chen, Hui, Gao, Xiao, Gong, Dongkui, Ma, Junjie, Kubra, Syeda, Yao, Xudong, Li, Xiaotao, Li, Lei, Zhai, Wei, Zheng, Junhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967313/ https://www.ncbi.nlm.nih.gov/pubmed/29795381 http://dx.doi.org/10.1038/s41419-018-0646-2 |
Ejemplares similares
-
REGγ regulates circadian clock by modulating BMAL1 protein stability
por: Kubra, Syeda, et al.
Publicado: (2021) -
Author Correction: The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells
por: Gao, Xiao, et al.
Publicado: (2020) -
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells
por: Gao, Xiao, et al.
Publicado: (2020) -
miR-195-5p is critical in REGγ-mediated regulation of wnt/β-catenin pathway in renal cell carcinoma
por: Chen, Shaojun, et al.
Publicado: (2017) -
The REGγ-Proteasome Regulates Spermatogenesis Partially by P53-PLZF Signaling
por: Gao, Xiao, et al.
Publicado: (2019)